Next Article in Journal
Multi Frequency Controllable In-Band Suppressions in a Broad Bandwidth Microstrip Filter Design for 5G Wi-Fi and Satellite Communication Systems Utilizing a Quad-Mode Stub-Loaded Resonator
Next Article in Special Issue
Metal-Chelating Self-Assembling Peptide Nanofiber Scaffolds for Modulation of Neuronal Cell Behavior
Previous Article in Journal
Influence of Pump Current Waveform on The Mitigation of Transverse Mode Instability in Fiber Laser Oscillator
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Micromachines
Volume 14
Issue 4
10.3390/mi14040865
micromachines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Brief Review on Cerium Oxide (CeO2NPs)-Based Scaffolds: Recent Advances in Wound Healing Applications

by
Ishita Allu
1,†,
Ajay Kumar Sahi
2,†,
Pooja Kumari
3,
Karunya Sakhile
4,
Alina Sionkowska
2,5,* and
Shravanya Gundu
1,*
1
Department of Biomedical Engineering, University College of Engineering (UCE), Osmania University, Hyderabad 500007, Telangana, India
2
Faculty of Chemistry, Nicolaus Copernicus University in Torun, Jurija Gagarina 11, 87-100 Toruń, Poland
3
Tissue Engineering and Biomicrofluidics Laboratory, School of Biomedical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, Uttar Pradesh, India
4
Department of Mechanical & Industrial Engineering, National University of Science and Technology, Muscat 2322, Oman
5
Faculty of Health Sciences, Calisia University, Nowy Świat 4, 62-800 Kalisz, Poland
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Micromachines 2023, 14(4), 865; https://doi.org/10.3390/mi14040865
Submission received: 6 March 2023 / Revised: 13 April 2023 / Accepted: 14 April 2023 / Published: 17 April 2023
(This article belongs to the Special Issue Biomaterials, Biodevices and Tissue Engineering)
Browse Figures
Versions Notes

Abstract

:
The process of wound healing is complex and involves the interaction of multiple cells, each with a distinct role in the inflammatory, proliferative, and remodeling phases. Chronic, nonhealing wounds may result from reduced fibroblast proliferation, angiogenesis, and cellular immunity, often associated with diabetes, hypertension, vascular deficits, immunological inadequacies, and chronic renal disease. Various strategies and methodologies have been explored to develop nanomaterials for wound-healing treatment. Several nanoparticles such as gold, silver, cerium oxide and zinc possess antibacterial properties, stability, and a high surface area that promotes efficient wound healing. In this review article, we investigate the effectiveness of cerium oxide nanoparticles (CeO2NPs) in wound healing—particularly the effects of reducing inflammation, enhancing hemostasis and proliferation, and scavenging reactive oxygen species. The mechanism enables CeO2NPs to reduce inflammation, modulate the immunological system, and promote angiogenesis and tissue regeneration. In addition, we investigate the efficacy of cerium oxide-based scaffolds in various wound-healing applications for creating a favorable wound-healing environment. Cerium oxide nanoparticles (CeO2NPs) exhibit antioxidant, anti-inflammatory, and regenerative characteristics, enabling them to be ideal wound healing material. Investigations have shown that CeO2NPs can stimulate wound closure, tissue regeneration, and scar reduction. CeO2NPs may also reduce bacterial infections and boost wound-site immunity. However, additional study is needed to determine the safety and efficacy of CeO2NPs in wound healing and their long-term impacts on human health and the environment. The review reveals that CeO2NPs have promising wound-healing properties, but further study is needed to understand their mechanisms of action and ensure their safety and efficacy.

1. Introduction

1.1. An Overview of Wound Healing

Skin is the largest organ in the human body, serving as a barrier to protect the internal organs of the body from external factors [1,2]. It is the most susceptible organ that can easily get damaged due to burns, wounds, cuts, and scrapes. Despite superficial wounds, it has a remarkable ability to self-repair. However, deeper wounds and larger defects require more complex treatments to heal completely. If these wounds are not treated properly, they may lead to persistent acute and chronic health issues including infections, tissue damage, and scarring, and can sometimes be fatal. Therefore, treating wounds promptly and effectively is vital to minimize the issues and promote full healing [1,3]. Since wound healing is a complex and dynamic process involving multiple stages and cellular mechanisms to restore the tissue’s functionality and prevent infections, delayed wound healing becomes a major issue by increasing prolonged hospitalization, chronic diseases such as diabetes and cardiovascular disease, and patient quality of life [4,5]. Thus, new wound healing methods are necessary. One promising strategy uses nanotechnology because of various properties such as enhanced drug delivery, improved wound closure, reduced scarring, biocompatibility, reduced inflammation, and antibacterial properties.
Nanomaterials have recently been developed for a variety of wound-healing applications. This is due to their higher surface-to-volume ratio, which is responsible for their distinct properties. These nanomaterials exhibit outstanding bactericidal, biocompatibility, and hemostatic capabilities [6]. Due to their small size, nanomaterials’ permeability and retention effects are improved, enabling the delivery of targeted drugs and the detection of malignancies. Several nanomaterials that can enhance wound healing without any adverse effects on the body have been evaluated. Some examples include zinc oxide, silica, gold, polycaprolactone, and silver nanoparticles. They have exhibited constructive results comprehending good biocompatibility, re-epithelialization, bactericidal activity, and reduced scar formation [7]. In particular, cerium oxide (CeO2NPs) stands out among the numerous nanomaterials utilized for wound healing applications as one of the most promising materials due to its outstanding antioxidant, anti-inflammatory, antibacterial, and angiogenic capabilities [8].
Consequently, there is a growing interest in using CeO2NPs for wound healing. This review will recapitulate the current research on the use of CeO2NPs for wound healing and emphasize their potential advantages and disadvantages. We have focused on the characteristics and mechanisms of action of CeO2NP-based scaffolds and wound-healing scaffolds/materials that aid in wound healing because they offer additional antibacterial, biocompatible, and hemostatic qualities that aid in the restoration of skin integrity [9]. Despite the availability of numerous therapies for wound healing, there is a need for more effective and efficient treatments. Recent research has demonstrated that CeO2NPs have the potential to enhance wound healing by promoting angiogenesis and collagen synthesis while minimizing inflammation and oxidative stress.

1.2. Phases of Wound Healing

An optimal wound healing process consists of four phases: hemostasis, inflammation, proliferation, and remodeling. Each of these stages and their physiological endeavors are performed in a cycle for an appropriate period [6]. The first phase of wound healing pertains to eliciting hemostasis by vasoconstriction, facilitating clot formation initiated by platelet aggregation at the wound site to minimize blood loss and provide a fibrin matrix formation which aids in cell migration essential for eventual phases of wound healing. Platelets are essential in the formation of clots and also promote multiple growth factors including transforming growth factor (TGF)-β, platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and epidermal growth factor (EGF) and cytokines which are used to regulate healing cascade. This phase lasts minutes to hours and moves into the inflammatory phase [10,11,12,13].
The inflammatory phase is a protective response stage which removes invading microorganisms and cellular debris from the wound site. This is accomplished by infiltrating neutrophils, lymphocytes, and macrophages into the affected tissue. Neutrophils migrate to the injury site and destroy invading pathogens. In addition, it generates reactive oxygen species and other chemical substances that contribute to killing pathogens and recruiting other immune cells at the inflammation site. T lymphocytes are essential components of cell-mediated immunity, which is the process by which the immune system detects and destroys aberrant or infected cells in the body. The function of macrophages in the healing process is multifaceted. They play a significant role in facilitating the removal of debris, bacteria, and injured cells at the wound site. They promote angiogenesis by secreting growth factors and releasing cytokines that stimulate cell proliferation and differentiation, leading to damaged tissue healing. In addition, macrophages stimulate apoptosis and the subsequent clearance of apoptotic cells, ultimately facilitating inflammation eradication. Following the inflammatory phase, the tissue aims at achieving angiogenesis, wound closure, and re-epithelialization by the action of fibroblasts, keratinocytes, macrophages, and other cells where collagen and extracellular matrix synthesis occurs, enabling wound repair [10,11,12,14,15].
After the inflammatory response, the wound becomes debris-free, and the proliferation phase begins. During this phase, the injured tissues are reconstructed using a variety of cellular and molecular mechanism pathways. Fibroblasts, endothelial cells, and myofibroblasts migrate to the wound site and rebuild new tissue. Fibroblasts are responsible for producing collagen, which is an essential protein for the structural integrity of the tissue to be maintained. Endothelial cells generate new blood vessels for tissue oxygenation and nourishment. Myofibroblast cells are specialized cells that help compress the wound and bring the edges closer after injury. As the incision heals, tissue strengthens and becomes stable, which lowers the likelihood of infection. The final and longest phase of wound healing is the remodeling phase, which intends to reorganize the extracellular matrix structures to maximize the tensile strength of the newly developed tissue and is marked by the formation of scar tissue having a more parallel collagen arrangement compared to normal tissue. The main traits of this phase are the deposition of collagen, the rearranging of fibers, and the contraction of scar tissue. In addition, the rate of wound healing and its effectiveness can be determined by various factors, including the patient’s age, the type and severity of the injury, and existing health conditions (Figure 1) [11,12,16].

1.3. CeO2NPs and Their Properties Suitable for Wound Healing

CeO2NPs, also referred to as nanoceria, have gained attention in wound healing due to their unique properties such as antioxidant, anti-inflammatory, anti-bacterial, and pro-angiogenic properties and biocompatibility. CeO2NPs decrease oxidative stress, inflammation, and wound size, and promote healing. In addition, they can enhance the catalase and superoxide dismutase (SOD) enzyme activity which protects cells from damage and supports curing [17]. The antioxidant property protects cells from oxidative stress, allowing Ce3+ and Ce4+ oxidation states to act as antioxidants and pro-oxidants [18,19]. It has extensive industrial applications in medical, optical and catalysis technology. In addition, they promote new angiogenesis, stimulate endothelial for cell proliferation, and enhance oxygenation nutrient supply to the wound site.
They have been extensively used in various applications, including corrosion protection, fuel oxidation catalysis, catalysis, electrochemistry, photochemistry, fuel cells, nitric oxide radicals, chemical mechanical polishing, and biomedical applications compared to other nanoparticles [20,21]. In addition, due to their thermal stability, great mechanical properties, good oxygen storage ability, and high retention on binding enzymes [22], CeO2NPs can be injected into tissues to protect against a broad range of oxygen-based reactive species, enhance the redox state of the blood, and improve wound healing effectiveness both in vitro and in vivo [23].

2. Role of CeO2NPs in Wound Healing Mechanism

For effective wound healing, rapid hemostasis, proliferation, and migration of cells to the wound site, as well as rapid re-epithelialization, are necessary [6]. CeO2NPs are of particular interest in radical-mediated reactions. Certain applications include diabetes mellitus, a condition marked by elevated blood glucose levels and afflicted insulin-producing β cells of the pancreas. Antioxidant CeO2NPs drastically reduce intracellular ROS levels, preventing β-cell apoptosis; another application includes the targeted destruction of cancer cells [24].

2.1. Properties of Reactive Oxygen Species (ROS) Scavenging and Antioxidants

A persistent wound eventuates when it fails to progress through the different phases of wound healing and this, in turn, induces more inflammation and greater levels of reactive oxygen species (ROS), which further prolongs the healing process due to increased oxidative stress. The effect of increased oxidative stress on cells is shown in Figure 2. The formation of antioxidant systems can lower ROS levels and hence minimize oxidative stress, one of the most important aspects of wound healing [9].
CeO2NPs allow ROS accumulation, exacerbating oxidative stress and ultimately leading to cancer cell apoptosis [25]. This is because they can act as either an oxidant or an antioxidant depending on the pH of the surrounding environment, which is depicted in Figure 3. The pH of cancer cells is acidic relative to the normal cells, prompting the pro-oxidative effect of CeO2NPs [25,26]. They also have a therapeutic effect on cerebral ischemia, a condition developed due to insufficient blood flow to the brain, resulting in oxygen deprivation in the cells and cell death. To restore normal blood flow, oxygen consumption is reduced in the mitochondria of neural cells, and this quick shift in oxygen levels results in the conversion of excessive oxygen into ROS and RNS (reactive nitrogen species). CeO2NPs are employed to reduce oxidative stress because of their antioxidative properties, and they also stimulate neurogenesis [24,27].
CeO2NPs were found to improve vascularization through their angiogenic properties, where CeO2NPs promoted the formation of new vessel networks by regulating intracellular oxygen and stabilizing vascular endothelial growth factor (VEGF) and Hypoxia-inducible factor-1 (HIF-1), which are pertinent in angiogenesis, cell proliferation, and other processes [29,30]. CeO2NPs can self-renew because they have valences of +3 or +4 allowing flexibility to switch between anti- and pro-oxidant states [19]. Due to this transition, they can switch between antioxidant and pro-oxidant capabilities, with pro-oxidant properties predominating at lower pH values [31]. CeO2NPs pro-oxidant nature allows them to cause oxidative stress, which could be beneficial in cancer treatment. Cancer cells, unlike normal cells, have a redox imbalance and produce abundant reactive oxygen species (ROS). The pro-oxidant activity of CeO2NPs is particularly important in this setting because the pH of tumor cells is typically decreased, allowing the pro-oxidant system to increase oxidative stress and eventually cause cell apoptosis [32], which would otherwise be hazardous in the biological environment [21].
CeO2NPs anti-oxidant characteristics, on the other hand, enable ROS scavenging by catalyzing the breakdown of ROS. Figure 4 demonstrates the pro-oxidant and antioxidant responses of CeO2NPs. Bone regeneration applications are one of the instances where CeO2NPs antioxidant potential is employed. In the case of a fracture or surgical wound, oxidative stress on the bone increases, resulting in the formation of free radicals, which might eventually lead to bone apoptosis. CeO2NPs can aid in eradicating these free radicals, enhancing biomineralization and overall mechanical characteristics [33]. The smaller Ce3+ particles boost this catalytic activity of ROS scavenging [34], maintaining the balance between ROS formation and destruction [35]. Therefore, the therapeutic strategy should direct CeO2NPs synthesis to minimize adverse body reactions [21]. Furthermore, higher Ce4+ ion concentration increases catalase mimetic activity, but higher Ce3+ ion concentration increases superoxidase dismutase (SOD) mimetic activity [36]. Catalase and SOD are antioxidant enzymes, which may be one of the fundamental mechanisms of CeO2NPs ROS scavenging abilities [37]. These characteristics make it a promising material for use in wound healing applications.
Another important aspect of the CeO2NPs is the therapeutic effects observed in the CeO2 NPs–microRNA (miR146a) conjugate. MicroRNAs are small noncoding RNA molecules that are significant to wound healing mechanisms. MicroRNAs, specifically miR146a, play a significant role in the regulation of inflammatory immune responses of the body by modulating the key inflammatory signals critical for wound healing [34,38,39,40,41,42]. In persistent chronic wounds, miR146a dysregulation may occur, hindering the wound healing procedure and requiring its supplementation to enhance the process [38,42]. However, miR146a cannot be administered directly due to its high degradability and the negative surface charge that causes electrostatic repulsion with the cell membrane, lowering cellular uptake and therapeutic efficacy. Therefore, they are generally conjugated with other inorganic nanoparticles such as silica, cerium oxide, and gold nanoparticles to stabilize and neutralize the negative charge and enhance the target delivery to the cells [34,38,43,44]. CeO2NPs are one of the most considered materials for conjugation with miR146a, as reports have suggested better cell targeting and reduced oxidative stress on the gene, ensuring improved delivery of miR146a to the targeted site and contributing to rapid wound healing [38,43,45]. The study conducted by Dawberry et al. found that administering a combination of CeO2NP (divalent metal oxides that scavenge free radicals) and miR146a (which controls the proinflammatory NF-B pathway) promotes diabetic wound healing. The study involved conducting immunohistochemistry and gene expression studies to determine how CeO2NP-miR146a promotes diabetic wound healing. The findings suggest that intradermal injection of CeO2NP-miR146a accelerates the healing of diabetic wounds by increasing wound collagen, promoting angiogenesis, reducing inflammation, and lessening the effects of oxidative stress. This is achieved by targeting the NF-B pathway and reducing oxidative stress, creating a wound environment favorable to angiogenesis and collagen production [46].

2.2. Effects on Reducing Inflammation and Modulating the Immunological System

The anti-inflammatory and immunomodulatory actions of a material pertain to its capability to alter the immune system’s response and diminish inflammation. Prolonged inflammation can lead to tissue damage and facilitates the emergence of diverse ailments, such as autoimmune disorders, cancer, and cardiovascular diseases. Inflammation is a normal immune system reaction to an injury or infection. Proinflammatory cytokines and chemokines, which stimulate immune cells to relocate to the site of inflammation, are inhibited when anti-inflammatory medications are used [47]. On the other hand, depending on the condition, immunomodulatory agents can either boost the immune system’s reaction or suppress it. Because of their valence and oxygen defect properties, CeO2NPs (nanoceria) may be autoregenerating free radical scavengers. The enzyme inducible nitric oxide synthase (iNOS) overproduces the free radical nitric oxide (NO), a major mediator of inflammation. A study by Suzanne et al. reported CeO2NPs scavenge ROS or free radicals and inhibit inflammatory mediator production in macrophages. They performed an in vivo study showing CeO2NPs deposition in mouse tissue without pathogenicity. A novel therapy for chronic inflammation could also be derived from nanoceria since it can reduce ROS production in states of inflammation [48].
Another study aiming to investigate the anti-inflammatory effect of CeO2NPs was reported. The primary objective was to investigate macrophage phenotype, cytokine expression, and proliferation under chronic and acute inflammatory conditions, and osteoinduction and differentiation of human mesenchymal stem cells (hBMSCs). They observed both acute and chronic conditions, iNOS activity decreased, and there was a significant increase in the anti-inflammatory cytokines gene in chronic inflammatory conditions. hBMSCs cultured without osteogenic media showed no increase in alkaline phosphatase (ALP) activity or mineral deposits, but a significant increase in calcium deposits, ALP activity, and osteogenic-related genes was expressed when CeO2NPs and osteogenic media were both supplemented [49].
Most NPs are captured by the spleen and liver irrespective of their dose difference, surface state, morphology, and aggregation. NPs clearance rate and cellular/tissue distribution in the body depend on NPs characteristics [50]. There is a need to develop new tools and concepts to understand the full potential and avoid the risk associated with NPs, as their pharmacokinetics significantly differ from traditional small molecules. A study demonstrated the long-term effect of CeO2NPs inside the body. They administrated 3 nm nanoceria at a concentration of 5.7 mg/kg body weight through an intravenous route in healthy mice. The biodistribution of CeO2NPs at different time points was measured in different organs such as the liver, brain, spleen, kidney, lungs, and brain, and in fecal and urinary excretion. They reported CeO2NPs accumulation in the spleen and liver, and their decay was exponential, with 50% of NPs excreted in 100 days. CeO2NPs does not damage any target organs; no weight loss or apathy was observed in experimental rats [50].

2.3. Facilitation of Angiogenesis and Tissue Regeneration

Angiogenesis is the process through which new blood vessels develop, assisting in the repair and restoration of damaged tissue, making it one of the most critical wound-healing elements [51]. There are several mechanisms to promote angiogenesis, one of which includes the use of growth factors, such as vascular endothelial growth factor (VEGF), that act as stimulants for blood vessel formation [52]. It also a play key role in delivering oxygen and nutrients to injury sites. Many studies have also shown that nanoparticles can stimulate angiogenesis by triggering certain signaling pathways involved in the development of vascular networks; among them are gold and mesoporous silica nanoparticles. Another approach is to employ stem cell therapy, which entails the differentiation of stem cells into various cell types that aid in the development of blood vessels [53]. Therefore, these are some of the techniques that may be incorporated to facilitate angiogenesis, thereby promoting tissue repair and regeneration and expediting the process of wound healing.

3. Potential Applications of CeO2NPs in Wound Healing

In biomedical engineering, polymers are frequently used to extend the application scope and enhance material characteristics. Polycarbonate and acrylic polymers are utilized in dentistry. PCL fibers are ideal for wound dressings and medication delivery [39]. Polymeric coatings are typically used for medical implants to increase hemocompatibility and prevent corrosion [42]. Due to their biomimetic properties, polymeric materials are also utilized as tissue regeneration scaffolds. Polymers can serve as matrices for encapsulating several nanoparticles, medications, and other substances, and as simple support structures [40,54]. Therefore, integrating CeO2NPs with other polymeric materials or nanofibers can broaden its application to wound healing by allowing for longer drug release at the wound site and accelerating the wound healing process, improving overall efficiency. Hereby, we have discussed a few recent and most relevant CeO2NP-conjugated polymeric scaffolds that have shown potential in wound healing applications.

3.1. CeO2NP-Incorporated PHBV Membranes

PHBV (poly(3-hydroxybutyrate-co-3-hydroxyvalerate)) is a biodegradable, nontoxic, and biocompatible polyhydroxyalkanoate-type polymer (Figure 5) [41]. PHBV cell membrane-encapsulated CeO2NPs have shown potential for treating diabetes-related wound healing complications. Such membranes were shown to have the ability to repair wounds in an experiment conducted on living animals using diabetic rats. PHBV membrane-based wound dressing matrices have been reported to enhance cell proliferation, migration, and angiogenesis. The electrospinning approach was utilized to fabricate nanofibers based on PHBV–cerium oxide nanoparticles. This method requires the preparation of PHBV solutions that include various amounts of CeO2NPs in a 9:1 ratio of chloroform to dimethyl formamide (DMF). Continuous nanoscale fibrous membranes were formed when a high voltage direct current (DC) power source was supplied, and these membranes were subsequently deposited on the collector [34]. The electrospinning approach produced highly porous nanofiber matrices that allowed oxygen and nutrients to diffuse freely, enabling quick and successful wound healing [43,55,56]. However, one significant disadvantage of this approach is the detrimental repercussions of DMF, a polar aprotic solvent, on vital organs, particularly the liver [57,58,59]. This can be mitigated by using a membrane distillation process, in which the vapor molecules are only permitted to travel over a hydrophobic membrane, eliminating any potential contaminants [60].

3.2. Cerium Oxide Nanoparticle-Containing Genipin Crosslinked Gelatin Hydrogel Composite (G-CeO2NPs)

Gelatin matrices are porous, allowing cells to move freely and providing mechanical and structural support for new tissue formation [38]. Their high biodegradability and biocompatibility have made them popular in wound healing applications. However, they cannot be used alone in biomedical applications due to their poor mechanical and antimicrobial properties and tendency to dissolve below 29 °C. Crosslinking with other polymers could improve these mechanical, bactericidal, and thermal properties [44,45,61,62]. Genipin was chosen as the crosslinking agent because of its high biocompatibility and ability to produce a stable crosslinked polymer [45,63]. It was found that the G-CeO2NPs composite cured wounds better than gelatin alone. In an in vivo investigation on rats, the G-ONPs composite exhibited rapid leukocyte movement and high collagen deposition rates, speeding up the wound healing process compared to other gelatin groups. For synthesizing CeO2NPs, the thermal decomposition method was utilized to decompose metal precursors in the presence of oleylamine, which acts as stabilizing agent to control the shape, size, and dispersion of resulting nanoparticles. Oleyalmine serves both as a reducing agent and a stabilizer, facilitating the thermal decomposition and formation of nanoparticles. To synthesize composite material, gelatin stock solution was mixed with CeO2NPs and then magnetically agitated. After that, genipin was added to the mixture to help generate crosslinks between gelatin and CeO2NPs [63] (Figure 6).

3.3. PVA/Chitosan-Incorporated Green-Synthesized Wound Healing Hydrogel

Polyvinyl alcohol (PVA) hydrogels are one of the most widely used polymeric materials for wound-healing applications due to their nonadherent nature and ease of removal from the wound [64]. Due to the high water content of hydrogels, they have sufficient flexibility and elasticity to fit the contour of the wound, making them an ideal material for wound dressings. However, because PVA alone has limited mechanical strength, composite hydrogel membranes are being fabricated to improve their usage in wound healing applications [65]. An article by Kalantari et al. reported synthesizing and evaluating a polyvinyl alcohol/chitosan (PVA/chitosan) hydrogel for wound healing applications. The hydrogel was incorporated with green-synthesized cerium oxide nanoparticles (CeO2NPs) using an extract from Zingiber officinale as the reducing, capping, and stabilizing agent. The PVA/chitosan/CeO2NPs hydrogel was developed using the freeze–thaw method with 0 to 1% (wt) 5 nm CeO2NPs as the active ingredient. Compared to the control group, the results showed that the hydrogels that included 0.5% CeO2NPs showed superior antibacterial activity after just 12 h. Hence, these chitosan/PVA hydrogels combined with CeO2NPs might be a promising contender as a strong wound dressing agent that may significantly diminish wound infections without resorting to antibiotics. This would be a significant advancement in treating chronic wounds [66].

3.4. PLA/PVA/PLA Trilayer Nanofibers with CeO2NPs

Polylactic acid (PLA) is a synthetic polymer obtained from natural sources widely employed in biomedical applications. It is one of the most prominent materials in the wound healing industry because of its exceptional mechanical and biocompatibility features [67,68]. PVA can absorb exudates and keep the wound moist. However, it cannot be used alone as a wound dressing due to its lack of bioactivity [69]. To aid in the healing of chronic wounds, Polylactic acid (PLA) and Polyvinyl alcohol (PVA) nanofibers (NFs) are sandwiched to produce a trilayer with CeO2NPs integrated into the nanofibers. Because PVA has a greater degradation rate, which could lead to ineffective and quick CeO2NPs release, it is coated with PLA, which has a lower degradation rate and assures a more regulated release of CeO2NPs from the inner PVA layer. This sustained release helps maintain the precise concentration of CeO2NPs in the wound, ensuring consistent and uninterrupted drug release for patients who require long-term treatment. The material’s overall mechanical and biocompatibility qualities are also improved, making it more effective than monolayer polymer membranes loaded with CeO2NPs [70]. The CeO2NP-loaded PLA/PVA/PLA trilayer NFs were prepared using the electrospinning method (Figure 7). Electrospun fibers exhibited high porosity, wettability, and resemblance to the natural extracellular matrix, promoting cell proliferation and migration and enhancing wound healing [71].
The outer layer of PLA was deposited on the collector following the electrospinning process. The same process was utilized to produce the middle layer, the CeO2NP-loaded PVA for a substantially longer length due to the greater thickness. The PLA solution was electrospun for the same length as the first layer to produce the third layer. The fibrous membranes deposited on the collector were carefully removed and stored at room temperature in a desiccator [72].

3.5. Polycaprolactone–Gelatin Nanofiber with CeO2NPs Functionalization (PGNPNF)

PCL is a synthetic polymer material exploited for wound-healing applications due to its exemplary biological and mechanical properties [73]. However, it could not be used aloneso due to its poor adhesivity. As a result, gelatin, a highly biodegradable and biocompatible polymer with exceptional nanofiber-forming capabilities, was employed in conjunction with PCL to aid in wound repair [60,69,71]. Nanofibers fabricated exhibited similar-to-optimal scaffolds as they offered greater surface area, porosity, and permeability, encouraging cell adhesion and proliferation [71]. Various investigations revealed that the PCL–gelatin nanofiber combination outperformed pure PCL regarding cell proliferation [60]. This composite was a support structure for the CeO2NPs, which had effective ROS scavenging properties [57]. PCL–gelatin nanofiber loaded with CeO2NPs was fabricated using the electrospinning process; 10% w/v of PCL and 20% w/v gelatin were combined in the hexafluoroisopropanol (HFIP) solvent for about 10 h, followed by 25% v/v of the 20 mM CeO2NPs suspension. This polymeric solution was made to discharge in the form of nanofibers over an aluminum foil [58]. The considerable decrease in PCL crystallinity that occurred as a result of gelatin blending showed a significant effect on the degradation behavior of the scaffold. SOD mimetic tests showed that the dissolution of uncrosslinked gelatin permitted the quick release of nanoparticles, whereas the use of PCL guaranteed that the structural integrity of nanofibers was maintained. In addition, the SOD mimetic activity demonstrates that PGNPNF has an antioxidant impact in a variety of buffer systems. In addition, the ability of PGNPNF to protect cells from the oxidative damage caused by Hydrogen peroxide is more evidence that the compound possesses antioxidant and cell protection properties. As a result, PGNPNF meshes, which have the potential to act as antioxidants, might be investigated for use as a wound dressing material (Figure 8).

3.6. Curcumin and CeO2NP-Integrated Dextran-Based Amphiphilic Nanohybrid Hydrogel System

Curcumin promotes rapid wound healing due to its excellent anti-inflammatory, antimicrobial, and antioxidant nature. Additionally, it had a greater ability to enhance tissue formation and remodeling [59]. However, it had limited applications due to its poor bioavailability and aqueous insolubility. Therefore, curcumin was integrated with 1-bromohexadecane-dextran, which acted as a carrier system for the curcumin formulations. Additionally, it was said to overcome the drawbacks of curcumin when administered as a primary wound-healing agent. In addition to curcumin, CeO2NPs were also incorporated, and delivered at the wound site to reduce inflammation and oxidative stress, thus promoting cell proliferation for rapid wound healing. The curcumin and CeO2NP-integrated O-hexadecyl-dextran were prepared using the freeze-drying method. The O-hexadecyl-dextran (HD) was prepared by dissolving dextran, NaOH, and 1-bromohexadecane-dextran in tetrahydrofuran (THF). The solution was then dialyzed and freeze-dried. The HD particles obtained were optimized by dissolving in Milli-Q-water followed by freeze-drying. The curcumin–acetone solution was then dropped into the previously produced solution, and the resulting mixture was lyophilized. The obtained curcumin-encapsulated nanoparticles and CeO2NPs were added to the gelatin solution to form the nanoparticle–hydrogel integrated system [64]. The hydrogel showed regulated and extended drug release and increased cell migration, and provided antioxidant and in vivo anti-inflammatory action. The study emphasizes the need to combine hydrogel and nanosystems to improve wound healing, drug transport, bioavailability, cytotoxicity, and therapeutic effects. Based on the promising results, more in vivo research is needed to translate its potential for quick wound healing into practical applications (Figure 9). Decellularized extracellular matrix (ECM) has been widely used for wound healing. However, ECM failed to integrate tissue and restore the tissue function properly when elevated levels of free radicals and biofilm formation occur at the wound site. To address this issue, a nanoemulgel system (DG-SIS/Ce/NC) was developed by combining nanoceria, curcumin nanoemulsion, and goat small intestine submucosa ECM gel. These nanoemulgel systems comprise decellularized ECM of caprine small intestine submucosa (DG-SIS), curcumin encapsulated eucalyptus oil-based nanoemulsion (Ce), and nanoceria (NC). The resulting formulation exhibited antibacterial, antioxidant, hemocompatible, biocompatible, and enhanced wound-healing properties. The DG-SIS/Ce/NC formulation showed the highest free radical scavenging capacity, sustained curcumin release, good skin permeability, increased cell proliferation, full-thickness wound contraction, and collagen synthesis. The enhanced wound healing is expected due to the synergistic effect of Ce, NC and DG-SIS. The reports have shown that DG-SIS/Ce/NC formulation holds potential for use as a nanoemulgel system in full-thickness wound healing applications [74].

3.7. Gelatin Methacryloyl Hydrogel Patch with CeO2NPs

Gelatin methacryloyl (GelMA) hydrogels are used in wound healing due to their hydrogel-like nature, allowing them to retain moisture and biocompatibility with the surrounding tissues [65]. Nevertheless, their usage is limited due to nonadhesiveness and poor mechanical strength [75]. However, they could be used conjointly with CeO2NPs, as this allowed for a combined benefit of free radical scavenging activity of CeO2NPs and controlled delivery of the drug at the injured site which otherwise would result in a rapid, excessive release of CeO2NPs which might turn out to be toxic. The CeO2NP-incorporated GelMA hydrogel patch was synthesized using ultrasonication wherein CeO2NPs were mixed with GelMA solution and crosslinked under UV irradiation. The resulting patches were lyophilized for roughly two days after being rinsed with demineralized water [75]. The findings of the study on wound healing demonstrated that diabetic rats treated with patches loaded with CeO2NPs exhibited significantly improved wound healing. The findings as a whole suggest that CeO2 NP-loaded GelMA hydrogels are among the most promising materials for the development of therapeutically applicable patches for the treatment of diabetic wounds.

3.8. CeO2NP Nanocomposite Hydrogels

Direct contact with several biomaterials, such as bioglass, can cause the biomaterial to adhere to the wound bed, which can lead to laceration and other negative wound responses [76]. Hydrogel is a type of hydrophilic polymer that naturally has a three-dimensional structure and has the potential to release therapeutic compounds as an appealing option to many other kinds of system techniques [77]. Hydrogels filled with cerium oxide nanoparticles, bioglass, or other components can prevent unfavorable responses. Both natural and synthetic biomaterials, such as alginate, collagen, and chitosan, can be utilized to produce hydrogels. In a study conducted by Chen et al., the researchers decided to employ photocrosslinkable and biodegradable gelatin methacryloyl (GelMA) as the backbone of the hydrogel. The study developed a multifunctional injectable composite hydrogel by combining cerium-containing bioactive glass with Gelatin methacryloyl hydrogel. The resulting hydrogel was cytocompatible, promoted endothelial cell migration and tube formation, and exhibited excellent antibacterial properties. In vivo studies on diabetic rats demonstrated that the hydrogel significantly improved wound healing by accelerating granulation tissue formation, collagen deposition, and angiogenesis. The study suggests that developing multifunctional materials with antibacterial and angiogenic properties can promote the repair of diabetic wound healing [78]. Recently, Gong et al. developed an injectable self-healing ceria-based nanocomposite hydrogel with ROS-scavenging activity to speed up wound healing. The dynamic Schiff base reaction crosslinked polyethyleneimine-coated cerium oxide nanorods with benzaldehyde-terminated F127 (F127-CHO) to create nanocomposite hydrogels (FVEC hydrogel). The FVEC hydrogel was thermosensitive, injectable, self-healing, and ROS-scavenging. It was biocompatible and biodegradable and improved wound healing and epithelial regeneration in full-thickness skin wound tests in mice. The study proposes a multifunctional CeO2NP-based nanocomposite hydrogel for wound healing and regeneration, which removes ROS and accelerates wound closure and tissue regeneration (Figure 10) [79].
Ma et al. conducted a study where they designed a multifunctional wound dressing possessing antibacterial properties, with the aim of expediting the process of wound healing. They prepared novel monodispersed sodium alginate–carboxymethyl chitosan (SA-CMCS) spheres at different ratios via crosslinking agent Ce3+. The antibacterial potential of the system is made more appealing to Staphylococcus aureus (S. aureus) and Escherichia coli by the progressive release of Ce3+ from the spheres (E. coli). In addition, the combination of SA and CMCS bestows the spheres with high biocompatibility, strong stability, and the capacity to speed up the healing process of wounds. The Electrospray method was utilized to generate Ce3+-crosslinked SA-CMCS spheres. These spheres can enhance wound healing and inhibit bacterial growth. The electrostatic spray approach was successfully used to generate Ce3+-crosslinked SA-CMCS spheres of millimeter size, displaying good antibacterial characteristics and effectively promoting wound healing. During the spinning process, various ratios of SA to CMCS were optimized. Among all, the SA-CMCS-1 spheres, out of all the SA-CMCS spheres, are the most stable, and their antibacterial power is the greatest due to the optimum Ce3+ release rate. This helps to prevent wound infection while the wound is healing. In addition, based on the high biocompatibility and wound-healing-encouraging effect of SA and CMCS, the SA-CMCS spheres, particularly the SA-CMCS-1 spheres, also demonstrate the capacity to enhance wound healing [80].

4. Discussion

Various scaffolds are being developed to assist in wound healing and tissue regeneration. Scaffolds of various biomaterials, such as polymers and metals, create wound-healing environments. Porosity, flexibility, biocompatibility, appropriate mechanical strength, and others are the qualities of scaffolds that promote quick wound healing [55,81]. Cerium oxide nanoparticles have been demonstrated as a potential material for addressing various issues and serving as antibacterial agents, redox elements, bioscaffolds, free radical scavengers, cancer treatment agents, biofilm inhibitors, and in many more biomedical applications. In addition, the fabrication of these nanoparticles via either physical, chemical, or biological methods may also assist in various fields, including solar cells, chemical mechanical polarization, and catalysis for fuel oxidation [82]. A few comparisons of various cerium oxide-based wound healing scaffolds are listed in Table 1. Dhall et al. discussed a novel method for fabricating cerium oxide nanoparticles, including a green synthesis method that provides safe routes to prepare CeO2NPs, that possess advantages, such as low cost, biocompatibility, enzyme mimetic activities, ROS scavenging activities, and others [21].
CeO2NPs are mainly used in biomedical applications because of their unique catalytic capabilities, low toxicity, bactericidal properties, excellent biocompatibility, and other factors. In this review, we discussed various CeO2NP-based scaffolds for wound healing applications, where CeO2NPs were combined with polymeric materials and hydrogels to improve their properties. Overall, the findings imply that CeO2NP-based composite scaffolds outperform hydrogels or other polymers used independently. As a result, the construction of such scaffolds would represent a significant advancement in treating chronic wounds. Chronic wounds are characterized by poor wound healing, which the development of a biofilm can trigger. The formation of a biofilm takes place when bacteria stick to the wound surface and begin to reproduce. This film secretes a glue-like matrix that protects the microorganisms within it from antimicrobial agents and the patient’s immunological response. As a result, avoiding biofilm formation is crucial [83]. In addition, biofilm may result from underlying diseases, such as diabetes, vascular disease, neuropathies, immunological inadequacy, and other similar conditions [84]. Understanding the pathophysiology of different types of wounds can lead to more accurate treatment techniques and, eventually, faster healing rates, leading to more successful wound treatments. Chronic wounds can be prevented from becoming infectious by practicing good wound care.

5. Conclusions

Wound healing is a complex process comprising hemostasis, inflammation, proliferation, and remodeling, and involving the coordination of various cellular and molecular mechanisms. Many factors can influence the healing process, including bacteria, infection, oxygenation, stress, foreign materials, and inflammation. Cerium oxide-based scaffolds have been shown to effectively combat these factors, leading to improved wound healing outcomes. These scaffolds have desirable properties, including anti-inflammatory and antibacterial effects against a wide range of pathogenic bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and the ability to promote tissue regeneration effects. This is achieved through the activation of various cellular and molecular pathways, including the promotion of angiogenesis, the activation of fibroblasts, and the stimulation of collagen synthesis. Despite the CeO2NPs possessing promising results, there are some challenges associated with their utilization, i.e., poorly established synthesis techniques, which makes it difficult to determine the size, shape, and dosage of CeO2NPs for wound healing. Although the antioxidant, anti-inflammatory, and antibacterial properties of CeO2NPs are well established, the exact mechanisms of action information are very limited. High-concentration dosage and long-term exposure may lead to toxicity. Regulatory approval is essential for product safety, and the manufacturer should adhere to predefined rules. Therefore, more research is needed to fully understand the mechanisms behind cerium oxide’s effects on wound healing. Cerium oxide-based scaffolds have become attractive for promoting wound healing in infected wounds. Further, these scaffolds can be utilized in clinical applications after optimizing and determining their effectiveness in different types of wounds and patient populations.

Author Contributions

I.A.: Original draft preparation, data curation, validation, and writing. A.K.S.: Original draft preparation, data curation, validation, and writing. P.K.: validation, reviewing, and editing. K.S.: reviewing and editing. S.G.: generated the figures, writing—review & editing. A.S.: Supervision, Project administration, reviewing and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This review work received no external funding.

Data Availability Statement

Data sharing not applicable since no new data were generated.

Acknowledgments

We would like to express our gratitude to biorender (licensed version) for allowing us to generate scientific graphics.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Riha, S.M.; Maarof, M.; Fauzi, M.B. Synergistic Effect of Biomaterial and Stem Cell for Skin Tissue Engineering in Cutaneous Wound Healing: A Concise Review. Polymers 2021, 13, 1546. [Google Scholar] [CrossRef]
  2. Qin, J.; Chen, F.; Wu, P.; Sun, G. Recent Advances in Bioengineered Scaffolds for Cutaneous Wound Healing. Front. Bioeng. Biotechnol. 2022, 10, 244. [Google Scholar] [CrossRef] [PubMed]
  3. Ho, J.; Walsh, C.; Yue, D.; Dardik, A.; Cheema, U. Current Advancements and Strategies in Tissue Engineering for Wound Healing: A Comprehensive Review. Adv. Wound Care 2017, 6, 191–209. [Google Scholar] [CrossRef] [PubMed]
  4. Spampinato, S.F.; Caruso, G.I.; De Pasquale, R.; Sortino, M.A.; Merlo, S. The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs. Pharmaceuticals 2020, 13, 60. [Google Scholar] [CrossRef] [PubMed]
  5. Jaul, E.; Barron, J.; Rosenzweig, J.P.; Menczel, J. An Overview of Co-Morbidities and the Development of Pressure Ulcers among Older Adults. BMC Geriatr. 2018, 18, 305. [Google Scholar] [CrossRef] [PubMed]
  6. Guo, S.; DiPietro, L.A. Factors Affecting Wound Healing. J. Dent. Res. 2010, 89, 219–229. [Google Scholar] [CrossRef]
  7. Nyoka, M.; Choonara, Y.E.; Kumar, P.; Kondiah, P.P.D.; Pillay, V. Synthesis of Cerium Oxide Nanoparticles Using Various Methods: Implications for Biomedical Applications. Nanomaterials 2020, 10, 242. [Google Scholar] [CrossRef]
  8. Cano Sanchez, M.; Lancel, S.; Boulanger, E.; Neviere, R. Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review. Antioxidants 2018, 7, 98. [Google Scholar] [CrossRef]
  9. Shalaby, M.A.; Anwar, M.M.; Saeed, H. Nanomaterials for Application in Wound Healing: Current State-of-the-Art and Future Perspectives. J. Polym. Res. 2022, 29, 91. [Google Scholar] [CrossRef]
  10. Wilkinson, H.N.; Hardman, M.J. Wound Healing: Cellular Mechanisms and Pathological Outcomes. Open Biol. 2020, 10, 200223. [Google Scholar] [CrossRef]
  11. de Oliveira Gonzalez, A.C.; Costa, T.F.; de Araújo Andrade, Z.; Medrado, A.R.A.P. Wound Healing—A Literature Review. An. Bras. Dermatol. 2016, 91, 614–620. [Google Scholar] [CrossRef] [PubMed]
  12. Velnar, T.; Bailey, T.; Smrkolj, V. The Wound Healing Process: An Overview of the Cellular and Molecular Mechanisms. J. Int. Med. Res. 2009, 37, 1528–1542. [Google Scholar] [CrossRef]
  13. Tottoli, E.M.; Dorati, R.; Genta, I.; Chiesa, E.; Pisani, S.; Conti, B. Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration. Pharmaceutics 2020, 12, 735. [Google Scholar] [CrossRef]
  14. Rausch, M.K.; Parekh, S.H.; Dortdivanlioglu, B.; Rosales, A.M. Synthetic Hydrogels as Blood Clot Mimicking Wound Healing Materials. Prog. Biomed. Eng. 2021, 3, 042006. [Google Scholar] [CrossRef] [PubMed]
  15. Schultz, G.S.; Chin, G.A.; Moldawer, L.; Diegelmann, R.F. Principles of Wound Healing. In Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists; University of Adelaide Press: Adelaide, Australia, 2011. [Google Scholar]
  16. van Zuijlen, P.P.M.; Ruurda, J.J.B.; van Veen, H.A.; van Marle, J.; van Trier, A.J.M.; Groenevelt, F.; Kreis, R.W.; Middelkoop, E. Collagen Morphology in Human Skin and Scar Tissue: No Adaptations in Response to Mechanical Loading at Joints. Burns 2003, 29, 423–431. [Google Scholar] [CrossRef] [PubMed]
  17. Mehta, A.; Scammon, B.; Shrake, K.; Bredikhin, M.; Gil, D.; Shekunova, T.; Baranchikov, A.; Ivanov, V.; Reukov, V. Nanoceria: Metabolic Interactions and Delivery through PLGA-Encapsulation. Mater. Sci. Eng. C 2020, 114, 111003. [Google Scholar] [CrossRef] [PubMed]
  18. Damle, M.A.; Jakhade, A.P.; Chikate, R.C. Modulating Pro- and Antioxidant Activities of Nanoengineered Cerium Dioxide Nanoparticles against Escherichia coli. ACS Omega 2019, 4, 3761–3771. [Google Scholar] [CrossRef]
  19. Nelson, B.C.; Johnson, M.E.; Walker, M.L.; Riley, K.R.; Sims, C.M. Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine. Antioxidants 2016, 5, 15. [Google Scholar] [CrossRef]
  20. Sharma, G.; Prema, D.; Venkataprasanna, K.S.; Prakash, J.; Sahabuddin, S.; Devanand Venkatasubbu, G. Photo Induced Antibacterial Activity of CeO2/GO against Wound Pathogens. Arab. J. Chem. 2020, 13, 7680–7694. [Google Scholar] [CrossRef]
  21. Dhall, A.; Self, W. Cerium Oxide Nanoparticles: A Brief Review of Their Synthesis Methods and Biomedical Applications. Antioxidants 2018, 7, 97. [Google Scholar] [CrossRef]
  22. Popova, N.; Andreeva, V.V.; Khohlov, N.V.; Popov, A.; Ivanov, V. Fabrication of CeO2 Nanoparticles Embedded in Polysaccharide Hydrogel and Their Application in Skin Wound Healing. Nanosyst. Phys. Chem. Math. 2020, 11, 99–109. [Google Scholar] [CrossRef]
  23. Ahmed, E.M.; Alkathiri, A.A. Enhanced Optical and Electrical Properties of CeO2 NPs/Chitosan Nanocomposites. Mater. Res. Express 2022, 9, 055305. [Google Scholar] [CrossRef]
  24. Abuid, N.J.; Gattás-Asfura, K.M.; LaShoto, D.J.; Poulos, A.M.; Stabler, C.L. Chapter 17—Biomedical Applications of Cerium Oxide Nanoparticles: A Potent Redox Modulator and Drug Delivery Agent. In Nanoparticles for Biomedical Applications; Chung, E.J., Leon, L., Rinaldi, C., Eds.; Micro and Nano Technologies; Elsevier: Amsterdam, The Netherlands, 2020; pp. 283–301. ISBN 978-0-12-816662-8. [Google Scholar]
  25. Gao, Y.; Chen, K.; Ma, J.-L.; Gao, F. Cerium Oxide Nanoparticles in Cancer. OncoTargets Ther. 2014, 7, 835–840. [Google Scholar] [CrossRef]
  26. Hao, G.; Xu, Z.P.; Li, L. Manipulating Extracellular Tumour PH: An Effective Target for Cancer Therapy. RSC Adv. 2018, 8, 22182–22192. [Google Scholar] [CrossRef] [PubMed]
  27. Estevez, A.Y.; Pritchard, S.; Harper, K.; Aston, J.W.; Lynch, A.; Lucky, J.J.; Ludington, J.S.; Chatani, P.; Mosenthal, W.P.; Leiter, J.C.; et al. Neuroprotective Mechanisms of Cerium Oxide Nanoparticles in a Mouse Hippocampal Brain Slice Model of Ischemia. Free Radic. Biol. Med. 2011, 51, 1155–1163. [Google Scholar] [CrossRef] [PubMed]
  28. Sadidi, H.; Hooshmand, S.; Ahmadabadi, A.; Javad Hoseini, S.; Baino, F.; Vatanpour, M.; Kargozar, S. Cerium Oxide Nanoparticles (Nanoceria): Hopes in Soft Tissue Engineering. Molecules 2020, 25, 4559. [Google Scholar] [CrossRef] [PubMed]
  29. Das, S.; Singh, S.; Dowding, J.M.; Oommen, S.; Kumar, A.; Sayle, T.X.T.; Saraf, S.; Patra, C.R.; Vlahakis, N.E.; Sayle, D.C.; et al. The Induction of Angiogenesis by Cerium Oxide Nanoparticles through the Modulation of Oxygen in Intracellular Environments. Biomaterials 2012, 33, 7746–7755. [Google Scholar] [CrossRef]
  30. Nosrati, H.; Aramideh Khouy, R.; Nosrati, A.; Khodaei, M.; Banitalebi-Dehkordi, M.; Ashrafi-Dehkordi, K.; Sanami, S.; Alizadeh, Z. Nanocomposite Scaffolds for Accelerating Chronic Wound Healing by Enhancing Angiogenesis. J. Nanobiotechnology 2021, 19, 1–13. [Google Scholar] [CrossRef]
  31. Dutta, D.; Mukherjee, R.; Ghosh, S.; Patra, M.; Mukherjee, M.; Basu, T. Cerium Oxide Nanoparticles as Antioxidant or Pro-Oxidant Agents. ACS Appl. Nano Mater. 2022, 5, 1690–1701. [Google Scholar] [CrossRef]
  32. Datta, A.; Mishra, S.; Manna, K.; Saha, K.D.; Mukherjee, S.; Roy, S. Pro-Oxidant Therapeutic Activities of Cerium Oxide Nanoparticles in Colorectal Carcinoma Cells. ACS Omega 2020, 5, 9714–9723. [Google Scholar] [CrossRef]
  33. Purohit, S.D.; Singh, H.; Bhaskar, R.; Yadav, I.; Chou, C.-F.; Gupta, M.K.; Mishra, N.C. Gelatin—Alginate—Cerium Oxide Nanocomposite Scaffold for Bone Regeneration. Mater. Sci. Eng. C 2020, 116, 111111. [Google Scholar] [CrossRef]
  34. Augustine, R.; Hasan, A.; Patan, N.K.; Dalvi, Y.B.; Varghese, R.; Antony, A.; Unni, R.N.; Sandhyarani, N.; Moustafa, A.-E.A. Cerium Oxide Nanoparticle Incorporated Electrospun Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate) Membranes for Diabetic Wound Healing Applications. ACS Biomater. Sci. Eng. 2020, 6, 58–70. [Google Scholar] [CrossRef]
  35. Comino-Sanz, I.M.; López-Franco, M.D.; Castro, B.; Pancorbo-Hidalgo, P.L. The Role of Antioxidants on Wound Healing: A Review of the Current Evidence. J. Clin. Med. 2021, 10, 3558. [Google Scholar] [CrossRef] [PubMed]
  36. Naganuma, T. Shape Design of Cerium Oxide Nanoparticles for Enhancement of Enzyme Mimetic Activity in Therapeutic Applications. Nano Res. 2017, 10, 199–217. [Google Scholar] [CrossRef]
  37. Ighodaro, O.M.; Akinloye, O.A. First Line Defence Antioxidants-Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid. Alex. J. Med. 2018, 54, 287–293. [Google Scholar] [CrossRef]
  38. Song, G.; Cheng, N.; Zhang, J.; Huang, H.; Yuan, Y.; He, X.; Luo, Y.; Huang, K. Nanoscale Cerium Oxide: Synthesis, Biocatalytic Mechanism, and Applications. Catalysts 2021, 11, 1123. [Google Scholar] [CrossRef]
  39. Shcherbakov, A.B.; Reukov, V.V.; Yakimansky, A.V.; Krasnopeeva, E.L.; Ivanova, O.S.; Popov, A.L.; Ivanov, V.K. CeO2 Nanoparticle-Containing Polymers for Biomedical Applications: A Review. Polymers 2021, 13, 924. [Google Scholar] [CrossRef]
  40. Dobrzyński, P.; Pamuła, E. Polymeric Scaffolds: Design, Processing, and Biomedical Application. Int. J. Mol. Sci. 2021, 22, 4552. [Google Scholar] [CrossRef]
  41. Rivera-Briso, A.L.; Serrano-Aroca, Á. Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate): Enhancement Strategies for Advanced Applications. Polymers 2018, 10, 732. [Google Scholar] [CrossRef]
  42. Sharma, P.; Nebhani, L. High Performance Hybrid Materials Based on Polybenzoxazines. In Reference Module in Materials Science and Materials Engineering; Elsevier: Amsterdam, The Netherlands, 2021; ISBN 978-0-12-803581-8. [Google Scholar]
  43. Han, I.; Shim, K.J.; Kim, J.Y.; Im, S.U.; Sung, Y.K.; Kim, M.; Kang, I.-K.; Kim, J.C. Effect of Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate) Nanofiber Matrices Cocultured with Hair Follicular Epithelial and Dermal Cells for Biological Wound Dressing. Artif. Organs 2007, 31, 801–808. [Google Scholar] [CrossRef]
  44. Ndlovu, S.P.; Ngece, K.; Alven, S.; Aderibigbe, B.A. Gelatin-Based Hybrid Scaffolds: Promising Wound Dressings. Polymers 2021, 13, 2959. [Google Scholar] [CrossRef]
  45. Raja, I.S.; Fathima, N.N. Gelatin–Cerium Oxide Nanocomposite for Enhanced Excisional Wound Healing. ACS Appl. Bio Mater. 2018, 1, 487–495. [Google Scholar] [CrossRef] [PubMed]
  46. Dewberry, L.C.; Niemiec, S.M.; Hilton, S.A.; Louiselle, A.E.; Singh, S.; Sakthivel, T.S.; Hu, J.; Seal, S.; Liechty, K.W.; Zgheib, C. Cerium Oxide Nanoparticle Conjugation to MicroRNA-146a Mechanism of Correction for Impaired Diabetic Wound Healing. Nanomed. Nanotechnol. Biol. Med. 2022, 40, 102483. [Google Scholar] [CrossRef]
  47. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory Responses and Inflammation-Associated Diseases in Organs. Oncotarget 2017, 9, 7204–7218. [Google Scholar] [CrossRef] [PubMed]
  48. Hirst, S.M.; Karakoti, A.S.; Tyler, R.D.; Sriranganathan, N.; Seal, S.; Reilly, C.M. Anti-Inflammatory Properties of Cerium Oxide Nanoparticles. Small 2009, 5, 2848–2856. [Google Scholar] [CrossRef]
  49. Wei, F.; Neal, C.J.; Sakthivel, T.S.; Kean, T.; Seal, S.; Coathup, M.J. Multi-Functional Cerium Oxide Nanoparticles Regulate Inflammation and Enhance Osteogenesis. Mater. Sci. Eng. C 2021, 124, 112041. [Google Scholar] [CrossRef] [PubMed]
  50. Ernst, L.M.; Mondragón, L.; Ramis, J.; Gustà, M.F.; Yudina, T.; Casals, E.; Bastús, N.G.; Fernández-Varo, G.; Casals, G.; Jiménez, W.; et al. Exploring the Long-Term Tissue Accumulation and Excretion of 3 Nm Cerium Oxide Nanoparticles after Single Dose Administration. Antioxidants 2023, 12, 765. [Google Scholar] [CrossRef]
  51. Adair, T.H.; Montani, J.-P. Overview of Angiogenesis; Morgan & Claypool Life Sciences: San Rafael, CA, USA, 2010. [Google Scholar]
  52. Johnson, K.E.; Wilgus, T.A. Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair. Adv. Wound Care 2014, 3, 647–661. [Google Scholar] [CrossRef]
  53. Descamps, B.; Emanueli, C. Vascular Differentiation from Embryonic Stem Cells: Novel Technologies and Therapeutic Promises. Vascul. Pharmacol. 2012, 56, 267–279. [Google Scholar] [CrossRef]
  54. Kumar Sahi, A.; Gundu, S.; Kumari, P.; Klepka, T.; Sionkowska, A. Silk-Based Biomaterials for Designing Bioinspired Microarchitecture for Various Biomedical Applications. Biomimetics 2023, 8, 55. [Google Scholar] [CrossRef]
  55. Sahi, A.; Varshney, N.; Poddar, S.; Gundu, S.; Mahto, S. Fabrication and Characterization of Silk Fibroin-Based Nanofibrous Scaffolds Supplemented with Gelatin for Corneal Tissue Engineering. Cells Tissues Organs 2021, 210, 173–194. [Google Scholar] [CrossRef] [PubMed]
  56. Gundu, S.; Varshney, N.; Sahi, A.K.; Mahto, S.K. Recent Developments of Biomaterial Scaffolds and Regenerative Approaches for Craniomaxillofacial Bone Tissue Engineering. J. Polym. Res. 2022, 29, 73. [Google Scholar] [CrossRef]
  57. Rather, H.A.; Thakore, R.; Singh, R.; Jhala, D.; Singh, S.; Vasita, R. Antioxidative Study of Cerium Oxide Nanoparticle Functionalised PCL-Gelatin Electrospun Fibers for Wound Healing Application. Bioact. Mater. 2018, 3, 201–211. [Google Scholar] [CrossRef]
  58. Fei, Y.; Huang, Q.; Hu, Z.; Yang, X.; Yang, B.; Liu, S. Biomimetic Cerium Oxide Loaded Gelatin PCL Nanosystems for Wound Dressing on Cutaneous Care Management of Multidrug-Resistant Bacterial Wound Healing. J. Clust. Sci. 2021, 32, 1289–1298. [Google Scholar] [CrossRef]
  59. Akbik, D.; Ghadiri, M.; Chrzanowski, W.; Rohanizadeh, R. Curcumin as a Wound Healing Agent. Life Sci. 2014, 116, 1–7. [Google Scholar] [CrossRef] [PubMed]
  60. Kuppan, P.; Sethuraman, S.; Krishnan, U.M. PCL and PCL-Gelatin Nanofibers as Esophageal Tissue Scaffolds: Optimization, Characterization and Cell-Matrix Interactions. J. Biomed. Nanotechnol. 2013, 9, 1540–1555. [Google Scholar] [CrossRef]
  61. Kirchmajer, D.M.; Watson, C.A.; Ranson, M.; in het Panhuis, M. Gelapin, a Degradable Genipin Cross-Linked Gelatin Hydrogel. RSC Adv. 2013, 3, 1073–1081. [Google Scholar] [CrossRef]
  62. Sahi, A.K.; Varshney, N.; Poddar, S.; Mahto, S.K. Comparative Behaviour of Electrospun Nanofibers Fabricated from Acid and Alkaline Hydrolysed Gelatin: Towards Corneal Tissue Engineering. J. Polym. Res. 2020, 27, 344. [Google Scholar] [CrossRef]
  63. Song, F.; Zhang, L.-M.; Yang, C.; Yan, L. Genipin-Crosslinked Casein Hydrogels for Controlled Drug Delivery. Int. J. Pharm. 2009, 373, 41–47. [Google Scholar] [CrossRef]
  64. Andrabi, S.M.; Majumder, S.; Gupta, K.C.; Kumar, A. Dextran Based Amphiphilic Nano-Hybrid Hydrogel System Incorporated with Curcumin and Cerium Oxide Nanoparticles for Wound Healing. Colloids Surf. B Biointerfaces 2020, 195, 111263. [Google Scholar] [CrossRef]
  65. Stan, D.; Tanase, C.; Avram, M.; Apetrei, R.; Mincu, N.-B.; Mateescu, A.L.; Stan, D. Wound Healing Applications of Creams and “Smart” Hydrogels. Exp. Dermatol. 2021, 30, 1218–1232. [Google Scholar] [CrossRef]
  66. Kalantari, K.; Mostafavi, E.; Saleh, B.; Soltantabar, P.; Webster, T. Chitosan/PVA Hydrogels Incorporated with Green Synthesized Cerium Oxide Nanoparticles for Wound Healing Applications. Eur. Polym. J. 2020, 134, 109853. [Google Scholar] [CrossRef]
  67. Gao, T.; Jiang, M.; Liu, X.; You, G.; Wang, W.; Sun, Z.; Ma, A.; Chen, J. Patterned Polyvinyl Alcohol Hydrogel Dressings with Stem Cells Seeded for Wound Healing. Polymers 2019, 11, 171. [Google Scholar] [CrossRef] [PubMed]
  68. Bi, H.; Feng, T.; Li, B.; Han, Y. In Vitro and In Vivo Comparison Study of Electrospun PLA and PLA/PVA/SA Fiber Membranes for Wound Healing. Polymers 2020, 12, 839. [Google Scholar] [CrossRef] [PubMed]
  69. Eskandarinia, A.; Kefayat, A.; Agheb, M.; Rafienia, M.; Amini Baghbadorani, M.; Navid, S.; Ebrahimpour, K.; Khodabakhshi, D.; Ghahremani, F. A Novel Bilayer Wound Dressing Composed of a Dense Polyurethane/Propolis Membrane and a Biodegradable Polycaprolactone/Gelatin Nanofibrous Scaffold. Sci. Rep. 2020, 10, 3063. [Google Scholar] [CrossRef]
  70. Azimi, B.; Maleki, H.; Zavagna, L.; De la Ossa, J.G.; Linari, S.; Lazzeri, A.; Danti, S. Bio-Based Electrospun Fibers for Wound Healing. J. Funct. Biomater. 2020, 11, 67. [Google Scholar] [CrossRef]
  71. Zheng, Y.; Liang, Y.; Zhang, D.; Sun, X.; Liang, L.; Li, J.; Liu, Y.-N. Gelatin-Based Hydrogels Blended with Gellan as an Injectable Wound Dressing. ACS Omega 2018, 3, 4766–4775. [Google Scholar] [CrossRef]
  72. Hussein, M.A.M.; Su, S.; Ulag, S.; Woźniak, A.; Grinholc, M.; Erdemir, G.; Erdem Kuruca, S.; Gunduz, O.; Muhammed, M.; El-Sherbiny, I.M.; et al. Development and In Vitro Evaluation of Biocompatible PLA-Based Trilayer Nanofibrous Membranes for the Delivery of Nanoceria: A Novel Approach for Diabetic Wound Healing. Polymers 2021, 13, 3630. [Google Scholar] [CrossRef]
  73. Raina, N.; Pahwa, R.; Khosla, J.K.; Gupta, P.N.; Gupta, M. Polycaprolactone-Based Materials in Wound Healing Applications. Polym. Bull. 2022, 79, 7041–7063. [Google Scholar] [CrossRef]
  74. Singh, H.; Bashir, S.M.; Purohit, S.D.; Bhaskar, R.; Rather, M.A.; Ali, S.I.; Yadav, I.; Makhdoomi, D.M.; Din Dar, M.U.; Gani, M.A.; et al. Nanoceria Laden Decellularized Extracellular Matrix-Based Curcumin Releasing Nanoemulgel System for Full-Thickness Wound Healing. Biomater. Adv. 2022, 137, 212806. [Google Scholar] [CrossRef]
  75. Augustine, R.; Zahid, A.A.; Hasan, A.; Dalvi, Y.B.; Jacob, J. Cerium Oxide Nanoparticle-Loaded Gelatin Methacryloyl Hydrogel Wound-Healing Patch with Free Radical Scavenging Activity. ACS Biomater. Sci. Eng. 2021, 7, 279–290. [Google Scholar] [CrossRef]
  76. Bao, F.; Pei, G.; Wu, Z.; Zhuang, H.; Zhang, Z.; Huan, Z.; Wu, C.; Chang, J. Bioactive Self-Pumping Composite Wound Dressings with Micropore Array Modified Janus Membrane for Enhanced Diabetic Wound Healing. Adv. Funct. Mater. 2020, 30, 2005422. [Google Scholar] [CrossRef]
  77. Xue, M.; Zhao, R.; Lin, H.; Jackson, C. Delivery Systems of Current Biologicals for the Treatment of Chronic Cutaneous Wounds and Severe Burns. Adv. Drug Deliv. Rev. 2018, 129, 219–241. [Google Scholar] [CrossRef] [PubMed]
  78. Chen, Y.-H.; Rao, Z.-F.; Liu, Y.-J.; Liu, X.-S.; Liu, Y.-F.; Xu, L.-J.; Wang, Z.-Q.; Guo, J.-Y.; Zhang, L.; Dong, Y.-S.; et al. Multifunctional Injectable Hydrogel Loaded with Cerium-Containing Bioactive Glass Nanoparticles for Diabetic Wound Healing. Biomolecules 2021, 11, 702. [Google Scholar] [CrossRef] [PubMed]
  79. Gong, X.; Luo, M.; Wang, M.; Niu, W.; Wang, Y.; Lei, B. Injectable Self-Healing Ceria-Based Nanocomposite Hydrogel with ROS-Scavenging Activity for Skin Wound Repair. Regen. Biomater. 2022, 9, rbab074. [Google Scholar] [CrossRef] [PubMed]
  80. Ma, T.; Zhai, X.; Huang, Y.; Zhang, M.; Li, P.; Du, Y. Cerium Ions Crosslinked Sodium Alginate-Carboxymethyl Chitosan Spheres with Antibacterial Activity for Wound Healing. J. Rare Earths 2022, 40, 1407–1416. [Google Scholar] [CrossRef]
  81. Gundu, S.; Sahi, A.K.; Varshney, N.; Varghese, J.; Vishwakarma, N.K.; Mahto, S.K. Fabrication and in Vitro Characterization of Luffa-Based Composite Scaffolds Incorporated with Gelatin, Hydroxyapatite and Psyllium Husk for Bone Tissue Engineering. J. Biomater. Sci. Polym. Ed. 2022, 33, 2220–2248. [Google Scholar] [CrossRef]
  82. Arunkumar, P.; Meena, M.; Babu, K.S. A Review on Cerium Oxide-Based Electrolytes for ITSOFC. Nanomater. Energy 2012, 1, 288–305. [Google Scholar] [CrossRef]
  83. Andrews, K.L.; Derby, K.M.; Jacobson, T.M.; Sievers, B.A.; Kiemele, L.J. Prevention and Management of Chronic Wounds. In Braddom’s Physical Medicine and Rehabilitation, 6th ed.; Cifu, D.X., Ed.; Elsevier: Philadelphia, PA, USA, 2021; pp. 469–484.e4. ISBN 978-0-323-62539-5. [Google Scholar]
  84. Chronic Wounds: Overview; Institute for Quality and Efficiency in Health Care (IQWiG): Cologne, Germany, 2018.
Micromachines 14 00865 g001 550
Figure 1. The progression of wound healing through various phases.
Figure 1. The progression of wound healing through various phases.
Micromachines 14 00865 g001
Micromachines 14 00865 g002 550
Figure 2. Adverse reaction of increased oxidative stress on the cells [7].
Figure 2. Adverse reaction of increased oxidative stress on the cells [7].
Micromachines 14 00865 g002
Micromachines 14 00865 g003 550
Figure 3. Pro-oxidant and antioxidant behavior of CeO2NPs with varying pH. Adapted from MDPI open access [28].
Figure 3. Pro-oxidant and antioxidant behavior of CeO2NPs with varying pH. Adapted from MDPI open access [28].
Micromachines 14 00865 g003
Micromachines 14 00865 g004 550
Figure 4. Implication of CeO2NPs in anticancer and cell recovery mechanisms. Adapted from MDPI open access [38].
Figure 4. Implication of CeO2NPs in anticancer and cell recovery mechanisms. Adapted from MDPI open access [38].
Micromachines 14 00865 g004
Micromachines 14 00865 g005 550
Figure 5. PHBV membrane with CeO2NPs for diabetic wound healing in vivo [34].
Figure 5. PHBV membrane with CeO2NPs for diabetic wound healing in vivo [34].
Micromachines 14 00865 g005
Micromachines 14 00865 g006 550
Figure 6. Fabrication of a gelatin hydrogel composite with cerium oxide nanoparticles (G-CeO2NPs) and crosslinking between the two using genipin [63].
Figure 6. Fabrication of a gelatin hydrogel composite with cerium oxide nanoparticles (G-CeO2NPs) and crosslinking between the two using genipin [63].
Micromachines 14 00865 g006
Micromachines 14 00865 g007 550
Figure 7. Fabrication of trilayer PLA/PVA/PLA nanofibers with CeO2NPs [72].
Figure 7. Fabrication of trilayer PLA/PVA/PLA nanofibers with CeO2NPs [72].
Micromachines 14 00865 g007
Micromachines 14 00865 g008 550
Figure 8. Wound healing via ROS scavenging using CeO2NPs loaded PCL-gelatin nanofibers [57].
Figure 8. Wound healing via ROS scavenging using CeO2NPs loaded PCL-gelatin nanofibers [57].
Micromachines 14 00865 g008
Micromachines 14 00865 g009 550
Figure 9. Synthesis of curcumin and CeO2NP-integrated Dextran-based amphiphilic nano-hybrid hydrogel system [64].
Figure 9. Synthesis of curcumin and CeO2NP-integrated Dextran-based amphiphilic nano-hybrid hydrogel system [64].
Micromachines 14 00865 g009
Micromachines 14 00865 g010 550
Figure 10. Representing TEM images of CeO2NPs–Bioglass nanocomposites i.e. (A) shows TEM images of 0 CeO2NP-BG, (B) 2 CeO2NP-BG and (C) 5 CeO2NP-BG. Adapted from MDPI open access [78].
Figure 10. Representing TEM images of CeO2NPs–Bioglass nanocomposites i.e. (A) shows TEM images of 0 CeO2NP-BG, (B) 2 CeO2NP-BG and (C) 5 CeO2NP-BG. Adapted from MDPI open access [78].
Micromachines 14 00865 g010
Table
Table 1. Comparison of various characteristics of cerium oxide-based scaffolds for wound healing.
Table 1. Comparison of various characteristics of cerium oxide-based scaffolds for wound healing.
Cerium Oxide-Based ScaffoldsFabrication TechniquesAdvantagesLimitationsApplicationsReferences
Polycaprolactone (PCL)–gelatin nanofiber with CeO2NPs functionalization (PGNPNF)ElectrospinningCell viability and proliferation were improved.
It reduced oxidative stress by lowering the number of reactive oxygen species (ROS).		Sustained delivery was not achieved because PCL breakdown was faster resulting in a rapid release of nanoparticles.Wound dressings[57]
Curcumin and
CeO2NP-integrated Dextran-based amphiphilic nanohybrid hydrogel system		Freeze dryingMedication release was controlled and delayed.
Cell migration and proliferation were enhanced which aided in the forming a new vascular network.		It was challenging to entrap hydrophobic curcumin inside hydrophilic nanoparticles.
Despite a greater rate of disintegration at first, the hydrogel did not disintegrate and was retained.		Drug delivery[64]
Gelatin methacryloyl hydrogel patch with CeO2NPsUltrasonicationThe porous structure promoted cell mobility and proliferation.
Excellent tensile mechanical characteristics and fluid retention capacity
Exudate from the wound surface was absorbed effectively.		During wound healing, a fibrotic scar developed, disrupting normal tissue arrangement.
Its long-term health consequences on humans are unclear.		Wound-healing patch for swift diabetic wound healing and chronic ulcer treatment.[75]
PHBV membranes incorporating CeO2NPsElectrospinningIt enhanced blood vessel development by promoting cell proliferation and adhesion.Reduced thickness of the formed epidermal layer.Wound dressings[34]
Gelatin and cerium oxide nanocompositeMagnetic stirringUltra-small holes enable
cell migration, nourishment, and oxygen exchange, accelerating wound healing.		To generate a membranous structure, an extra crosslinking agent was needed [26].Wound dressings[45]
Polyvinyl alcohol nanogels with CeO2NPsFreeze- thawingIts high elasticity enabled it to wound easily.
Improved fluid retention capacity, which allowed for speedier wound healing.		Maximum strength was reduced.Wound dressings[66]
PLA/PVA/PLA tri-layer nanofibers (NFs) loaded with CeO2NPsElectrospinningCell adhesion, growth, and proliferation were all improved.
Improved biocompatibility and mechanical characteristics.
This allowed for a more steady and long-lasting release of the drug.		A high amount of CeO2NPs was needed to generate a more stable trilayer.Drug delivery[72]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Allu, I.; Kumar Sahi, A.; Kumari, P.; Sakhile, K.; Sionkowska, A.; Gundu, S. A Brief Review on Cerium Oxide (CeO2NPs)-Based Scaffolds: Recent Advances in Wound Healing Applications. Micromachines 2023, 14, 865. https://doi.org/10.3390/mi14040865

AMA Style

Allu I, Kumar Sahi A, Kumari P, Sakhile K, Sionkowska A, Gundu S. A Brief Review on Cerium Oxide (CeO2NPs)-Based Scaffolds: Recent Advances in Wound Healing Applications. Micromachines. 2023; 14(4):865. https://doi.org/10.3390/mi14040865

Chicago/Turabian Style

Allu, Ishita, Ajay Kumar Sahi, Pooja Kumari, Karunya Sakhile, Alina Sionkowska, and Shravanya Gundu. 2023. "A Brief Review on Cerium Oxide (CeO2NPs)-Based Scaffolds: Recent Advances in Wound Healing Applications" Micromachines 14, no. 4: 865. https://doi.org/10.3390/mi14040865

APA Style

Allu, I., Kumar Sahi, A., Kumari, P., Sakhile, K., Sionkowska, A., & Gundu, S. (2023). A Brief Review on Cerium Oxide (CeO2NPs)-Based Scaffolds: Recent Advances in Wound Healing Applications. Micromachines, 14(4), 865. https://doi.org/10.3390/mi14040865

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop